Evolent Health, Inc. (NYSE:EVH) Q2 2025 Earnings Call Transcript
Operator: Welcome to the Evolent Earnings Conference Call for the second quarter ended June 30, 2025. As a reminder, this conference call is being recorded.
Evolent Health Inc. (EVH)
Market is closed
Sector: Services-Management Services
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Cadian Capital Eric Bannasch | 10,424,701 | $117,382,133 | -4% | 6.57% |
| 2. | Durable Capital Partners Henry Ellenbogen | 6,423,293 | $72,326,279 | 0.55% | |
| 3. | Engaged Capital Glenn W. Welling | 5,854,468 | $65,921,310 | +14% | 18.43% |
| 4. | 38,213,000 | $37,752,725 | 1.26% | ||
| 5. | 8 Knots Management Scott J. Green | 2,913,135 | $32,801,900 | 4.7% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $9.33 | 2,735 | $25,517.55 | 70,584 | 2025-03-06 | Filing | |
| $9.01 | 11,040 | $99,470.40 | 389,004 | 2025-03-06 | Filing | |
| $9.09 | 15,000 | $136,350.00 | 15,000 | 2025-03-07 | Filing | |
| $9.16 | 15,000 | $137,400.00 | 15,000 | 2025-03-07 | Filing | |
| $9.01 | 11,040 | $99,470.40 | 18,749 | 2025-03-06 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $33.00 | 4,000 | $132,000.00 | 188,340 | 2024-08-23 | Filing | |
| $32.00 | 6,469 | $207,008.00 | 192,340 | 2024-08-23 | Filing | |
| $33.00 | 7,000 | $231,000.00 | 198,809 | 2024-08-22 | Filing | |
| $30.00 | 16,693 | $500,790.00 | 205,809 | 2024-08-22 | Filing | |
| $30.00 | 16,887 | $506,610.00 | 167,027 | 2024-08-22 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 10,921,531 | $122,976,439 | 0% | |
| 2. | 108,650,000 | $107,767,221 | 1.45% | |
| 3. | 125,100,000 | $106,679,900 | 0.65% | |
| 4. | 9,376,620 | $105,580,741 | 0% | |
| 5. | 8,052,587 | $90,672,143 | 0.01% |
News See All
Evolent Health (EVH) Bolsters Management Team
Evolent Health, Inc. (NYSE:EVH) is one of the top 10 medical AI companies to buy according to analysts. On July 9, the company strengthened its leadership team with the appointment of Dr.
Top 10 Medical AI Companies to Buy According to Analysts
Artificial intelligence is transforming medical sciences in ways not seen before.
JMP Maintains Price Target and Market Outperform Rating on Evolent Health (EVH)
JMP Securities reaffirmed its Market Outperform rating and $13.00 price target on Evolent Health, Inc. (NYSE:EVH), highlighting a more stable and promising outlook for the company.
Top 10 Healthcare AI Stocks to Buy According to Hedge Funds
“Healthcare is the most underappreciated AI beneficiary,” said Ark Invest CEO Cathie Wood in a recent statement that’s reverberating across Wall Street.
Evolent Health, Inc. (NYSE:EVH) Q1 2025 Earnings Call Transcript
Operator: Welcome to the Evolent Health, Inc. earnings conference call for the first quarter ended March 31, 2025. As a reminder, this conference call is being recorded.
12 Stocks That Are About to Explode
Despite the current headwinds and uncertainty (which also caused heightened volatility in the last 2 weeks), there are indications that the recent US stock market correction was short-lived, and the market...
Here’s What Challenged Evolent Health (EVH) Despite Strong Revenue Growth
Carillon Tower Advisers, an investment management company, released its “Carillon Eagle Small Cap Growth Fund” fourth quarter 2024 investor letter. A copy of the letter can be downloaded here.
Evolent Health, Inc. (NYSE:EVH) Q4 2024 Earnings Call Transcript
Operator: Welcome to the Evolent Earnings Conference Call for the Fourth Quarter and Year End December 31, 2024. [Operator Instructions] As a reminder, this conference call is being recorded.
10 Stocks That Will Bounce Back According To Hedge Funds
With 2024 coming to a close, investors have left several unknown variables behind them. They started out the year wondering when and if the Federal Reserve would start cutting interest rates.
Billionaire Hedge Funds
